Global Apoptosis Assays Market

Apoptosis Assay Market Insights

The apoptosis assay market is expected to grow at a high CAGR during the forecast period. Apoptosis plays an important role in preventing overgrowth of neuronal cell lineages in the developing brain and helps to regulate spacing in limb development. Development of new drug therapies and emergence of new clinical trials are expected to propel the market growth for apoptosis assays during the forecast period. Rising prevalence of chronic and infectious disease is one of the major factors propelling the market growth. Increasing cell based study and rise in funds for cancer research are also driving the market growth. However, high investments required for research and development are likely to hamper the market growth over the coming years.

Apoptosis Assays market: By Product

On the basis of product, the market is segmented into assay kits, reagents, microplates and instruments. Assay kits are expected to grow at a high CAGR during the forecast period. Assay kits include annex v and other method of detection that are fast and reliable source of detection of cell surface changes in regard to apoptosis. The adoption of assay kits in multiple procedures like environmental monitoring, life science research is also propelling the market growth.  Assay kits are used in the screening of drug candidates, evaluating biopharmaceutical production processes and studying disease among others.

Apoptosis Assays market: By Detection Technology

On the basis of detection technology, the market is segmented into flow cytometry and florescence microscopy. Flow cytometry is expected to hold the largest market share during the forecast period. Flow cytometry enables the examination of mixed origin cell samples, and offers flexible and quantitative single cell data.  Florescence microscopy is expected to grow at a high CAGR during the forecast period. Fluorescence microscopy can be used to observe chromatin condensation, nuclear shrinkage and formation of apoptotic bodies after staining of nuclei with DNA specific fluorochromes.

Apoptosis Assays market: By Application

On the basis of application, the market is segmented into stem cell, discovery & development and clinical research. Stem cell segment is expected to hold the largest market share during the forecast period. Apoptosis of stem cells is a dynamic process where the release of stem cells factor prevents apoptosis in case of spinal cord injury promoting tissue repair. Increasing adoption of cell imaging and microscopy in diagnostic laboratories, drug discovery applications, and basic research are also driving the market growth. Discovery and development segment are expected to grow at a high CAGR during the forecast period. Antiapoptotic drugs in advanced development stage are targeting acute disease such as stroke, myocardial infarction and sepsis. There is scope of apoptosis drug discovery in the pharmaceutical products and anti-apoptotic therapy which will decrease the mortality from strokes and sepsis leading to the segment demand in the market.

Apoptosis Assays market: By Region

On the basis of region, the market is segmented into North America, Asia-Pacific, Europe, CSA and Middle East & Africa. The Asia-Pacific region is expected to grow at a high CAGR during the forecast period. Extensive R&D in drug discovery, government expenditure in clinics and presence of big manufacturers to supply products and kits are the major factors expected to propel the market growth in the region. Growing advancements in stem cell discovery, vital drugs in the market and rise in the number of hospitals and clinics are driving the market growth in the region.

Apoptosis Assay Market Share and Competitor analysis

Some of the key players operating in the market include: Merck KGaA, GE Healthcare, Danaher Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, Becton, Dickinson and Company, Geno Technology and GeneCopoeia, Inc.

Please note: This is not an exhaustive list of companies profiled in the report.

In 2018, Thermo Fisher Scientific launched Multiskan Sky Microplate Spectrophotometer.

In 2017, Becton, Dickinson and Company acquired C.R Bard (US). This acquisition advanced BD’s product offerings and global reach.

In 2018, GE Healthcare Life Sciences opened a new production facility in Pasching, Austria. The newly built manufacturing site will help to strengthen product supply for biopharmaceutical companies in Europe.

Check the Press Release on Global Apoptosis Assays Market Report